THOR is a targetable epigenetic biomarker with clinical implications in breast cancer

BACKGROUND: Breast cancer (BC) is the most frequently diagnosed cancer and a leading cause of death among women worldwide. Early BC is potentially curable, but the mortality rates still observed among BC patients demonstrate the urgent need of novel and more effective diagnostic and therapeutic opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Apolónio, Joana Dias, Dias, João S., Fernandes, Mónica Teotónio, Komosa, Martin, Lipman, Tatiana, Zhang, Cindy H., Leão, Ricardo, Lee, Donghyun, Nunes, Nuno Miguel, Maia, Ana-Teresa, Morera, José L., Vicioso, Luis, Tabori, Uri, Castelo-Branco, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759897/
https://www.ncbi.nlm.nih.gov/pubmed/36529814
http://dx.doi.org/10.1186/s13148-022-01396-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759897/
https://www.ncbi.nlm.nih.gov/pubmed/36529814
http://dx.doi.org/10.1186/s13148-022-01396-3

Ejemplares similares